Seeing Is Believing
with an average price target of $17.45. This is a potential upside of $17.45 (0%) from yesterday's end of day stock price of $0.
Aimmune Therapeutics's activity chart (see below) currently has 134 price targets and 96 ratings on display.
Analysts average stock forecasts to be materialized ratio is 35.02% with an average time for these price targets to be met of 113.21 days.
Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 31-Aug-2020. First documented stock forecast 30-Aug-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$18
5 years 1 months 24 days ago
(31-Aug-2020)
3/3 (100%)
$3.19 (21.54%)
78
Hold
$60
5 years 1 months 24 days ago
(30-Aug-2020)
0/19 (0%)
$41.31 (221.03%)
Hold
$34.5
$0.01 (0.03%)
$66
5 years 1 months 24 days ago
(30-Aug-2020)
1/8 (12.5%)
$0.28 (0.82%)
39
Hold
$34.5
$0.01 (0.03%)
$14
5 years 1 months 24 days ago
(30-Aug-2020)
7/7 (100%)
$0.28 (0.82%)
105
Hold
$35
$0.51 (1.48%)
$24
5 years 1 months 24 days ago
(30-Aug-2020)
7/17 (41.18%)
$0.78 (2.28%)
376
What is AIMT (Aimmune Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AIMT (Aimmune Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AIMT (Aimmune Therapeutics)?
Which analyst is the currently most bullish on AIMT (Aimmune Therapeutics)?
Which analyst is the currently most reserved on AIMT (Aimmune Therapeutics)?